ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions.

With limited finances and a modest hourly wage from his trucking job, the man had to make a devastating choice: buy his ...

After Uber Eats sparked controversy last year with a planned Super Bowl commercial that poked fun at anaphylaxis, Food Allergy Research & Education worked with the company to change the ad and promote ...

Confusion between approved injectable epinephrine products and unapproved nasal solutions has prompted a warning to ...

Chronic stress leads to elevated stress hormones, which may be linked to bone breakdown. Puerto Rican adults living on the US mainland have higher prevalence of stress than the general population, and ...

A milk allergy and lactose intolerance can cause similar symptoms after consuming dairy, but they are not the same. Here are ...

Report Ocean’s recent report provides an accurate and comprehensive research analysis of the “Saudi Arabia Epinephrine Autoinjector Market” with a primary focus on the present and past market ...

Since 2016, the FDA has received 25 reports of unapproved epinephrine nasal solution being confused with approved epinephrine injection.

This complaint was first surfaced by Law.com Radar, ALM's source for immediate alerting on just-filed cases in state and federal courts. Law.com Radar now offers state court coverage nationwide. Sign ...

Oversecretion of aldosterone is a consistent finding in the syndrome of malignant hypertension. Infusion of angiotensin has been consistently shown to induce an increased secretion of aldosterone by ...

“Many Indiana residents rely on these medications to stay alive. Hoosiers deserve to know that the prices they pay for epinephrine arise from free and fair competition.” The lawsuit alleges the ...

(Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from allergic reactions that could lead to anaphylaxis, today announced ...